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Summary The prognostic value of the TNM classifications of the UICC dated 1978 and 1987, was
investigated in a population of 2,495 patients who were followed up over the long term. In the case ofprimary
melanoma, Breslow's tumour thickness proved to be the most powerful predictor of patient survival in
multivariate analysis, while the significance of Clark's level ranged after that of both localisation of the
primary tumour and the sex of the patient.
The continuous proportional relationship between tumour thickness and risk of death makes it possible to
regrade thickness groups. Grading cutoffs at 1, 2 and 4 millimetres, with no account being taken of depth of
invasion, proved to be particularly favourable for a classification in accordance with prognostic criteria. In
advanced stages of the disease, the outcome oflocoregional and distant metastasis is significantly different; and
furthermore in the case of locoregional metastasis, in-transit and satellite metastases exert a significantly better
prognosis than regional lymph node involvement.
Isolated juxtaregional lymph node metastases occurred primarily or during the course of the observation
period in only 19 patients of our group, and, in comparison with visceral metastases, proved to have only an
insignificantly better prognosis. For this reason, it would appear meaningful to assign them to a common
stage. On the basis of these results, proposals are made for modifications of the TNM classification.
With the introduction of new therapeutic concepts aimed at
providing a more highly differentiated prognosis-oriented
treatment of malignant melanoma, the need for a new
classification that permits an accurate description of the
tumour and its prognosis has become more urgent.
The TNM classifications issued by the UICC are those
most commonly employed world-wide, and the 1978 version
has found general acceptance in German-speaking countries.
In these classifications, histological criteria (tumour thickness
as defined by Breslow, Clark's level), and the anatomical
spread of the tumour are employed postoperatively to define
the stage of the disease. Table I shows the basic differences
between the two versions: while the 1978 version is oriented
predominantly to the anatomical spread of the tumour, the
1987 TNM classification takes greater account of the
differences in the prognosis of primary melanomas. In this
version, a primary tumour of a given thickness, but without
metastatic disease, may be classified as Stage III, while in the
earlier version, all those melanomas limited to the site of
their origin were placed in Stage I.
The extent to which these classifications permit a progno-
stically meaningful grading, as also possibilities for improve-
ment, were studied in a large population of patients followed
up over the long term. Particular atten4oh was directed to
the following questions:
(a) Are tumour thickness and level of invasion suitable
parameters for a prognosis-oriented description of pri-
mary malignant melanomas?
(b) What is the significance of Clark's level for staging?
(c) Is it possible to optimise the criterion tumour thick-
ness by adopting new grading cutoffs?
(d) Are we justified in considering the stages as presently
defined by the TNM classification to be homogeneous in
terms of prognosis?
On the basis of our results, proposals are made for
optimising the TNM classification for malignant melanoma.
Material and methods
Patient data collected in the dermatological departments of
three German universities formed the basis of the present
study. In Berlin, Tubingen and Wiirzburg, all patients con-
secutively presenting for dermatological treatment between
1970 and 1987, in whom the diagnosis 'malignant melanoma'
was established were documented for this study. The evalua-
tion encompassed a total of 2,495 patients with invasive
malignant melanomas of the skin, in whom the primary
tumour was removed completely by an operative procedure,
and who were followed up for a period of at least three
months. For the multivariate analysis of the data obtained,
the regression analysis (computer program BMPD 2L) des-
cribed by Cox in 1972 was employed. In this model, the
following factors were considered:
Age and sex of the patient, localisation and histological
status of the tumour (tumour thickness as described by Bres-
low, Clark's level, histological type), margin of clearance at
surgery, the year in which diagnosis was established, and the
centre at which treatment was provided.
Survival rates were determined on the basis of the actuarial
method (life tables) (Cutler & Ederer, 1958) and analysed for
significant differences with the aid of the test described by
Lee and Desu (1972), (computer program SPSS Survival).
Results
Comparison of1978 and 1987 TNM - Criteria
Application of the TNM criteria to the data material inves-
tigated led to a classification into four or five groups respec-
tively, for the two classifications, for which the survival rates
within a 10-year period were calculated.
An element common to the two classifications is a 10-year
survival rate for Stage I or Ia respectively of more than 90%,
with a virtually horizontal curve and the precipitous drop in
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Table I TNM - classifications of malignant melanoma (1978 and 1987 Versions)
1978 Version
pTl,pT2
pT3,pT4
every pTa,pTb
every pT
every pTa,pTb
every pT
every pTa,pTb
every pT
every pTa,pTb every pN
pNO
pNO
pNO
pNl
pNl
pN4
pN4
every pN
pMl
Stage
I pMO
pMO
pMO
pMO
pMO
pMO
pM0
pMl
pTl: tumour thickness <0.75 mm and Level II
pT2: tumour thickness>0.75- 1.5 mm and/or Level III
pT3: tumour thickness>1.5-3 mm and/or Level IV
pT4: tumour thickness>3 mm and/or Level V
pNl: regional lymph node metastasis
pN4: juxtaregional lymph node metastasis
1987 Version
pTl
pT2
pT3
III pT4
every pT
IV every pT
pNO
pNO
pNO
pNO
pNl,pN2
every pN
pMO
pMO
pMO
pMO
pMO
every pMl
tumour thickness <0.75 mm and Level II
tumour thickness>0.75- 1.5 mm and/or Level III
tumour thickness>1.5-4 mm and/or Level IV
tumour thickness>4 mm and/or Level V/Satellites
pN1: regional lymph node metastasis < 3 cm
pN2: regional lymph node metastasis>3 cm
and/or in-transit metastasis
pTa: satellite metastasis
pTb: in-transit metastasis
pM 1: distant metastasis pM 1: distant metastasis
the curve for Stage IV, which approaches zero after a period
of only 15 months. Within this framework, the survival
curves for the other stages vary to differing degrees, ending at
different levels on completion of the 10-year period (Figure 1,
Table II).
Breslow's thickness and Clark's level
The value of the criteria tumour thickness and Clark's level
for the prognosis of malignant melanoma in Stage I is made
apparent by a multivariate analysis that takes into account
the factors mentioned above. In this connection, the most
important parameter proved to be the vertical thickness of
the primary tumour, followed by its localisation and the sex
of the patient.
In comparison, Clark's level proved to be of only secon-
dary importance, acquiring additional significance only at
level III as compared with II in thin tumours.
TNM-1978 version
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Table II Ten-year survival rates in accordance with the criteria ofthe
TNM-Classification
Ten-year survival rates in percent
1978 TNM version 1987 TNM version
stage I - 91.7
stage Ia 91.7
stage Ib 62.3
stage II 22.7 68.0
stage III <8 31.4
stage IV 1.8 1.8
In Table III, which illustrates this relationship, the
likelihood value is employed as a measure for the weighting
of the respective variables in terms of their significance for
survival. The right-hand column indicates the relative risk of
TNM-1987 version
I 0 12 24 36 48 60 72 84 96 108 120
MAnnthc:
* Stagela l Stage -- X-Stage IV Stage Stage III
* Stage lb -x- Stage III * Stage IV -x- Stage II
Figure 1 Ten-year survival rates in accordance with the criteria of the TNM-classification in the 1978 and the 1987 version
respectively.
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Table III Stepwisemultivariate analysisofindependentprognosticfactorsforprimary
melanoma, significance ofdifferent classifications ofBreslow's thickness and ofClark's
level in the Cox Hazard regression analysis
Step 1: Log likelihood Relative risk
Tumour thickness>1.5-3 mm vs>0.75-1.5 mm - 2308.663 3.03
Localisationa - 2292.581 1.76
Tumour thickness > 3 mm vs>1.5-3 mm - 2276.732 2.17
Level> III vs II - 2264.713 4.99
Sex - 2256.751 1.59
Step 2:
Tumour thickness> 1.5-4 mm vs>0.75-1.5 mm - 2308.663 3.46
Localisationa - 2292.581 1.74
Level> III vs II - 2281.395 4.73
Tumour thickness >4 mm vs>1.5-4 mm - 2268.994 2.19
Sex - 2261.488 1.56
Step 3:
Tumour thickness>2-4 mm vs>1 -2 mm - 2308.407 2.34
Tumour thickness>1-2 mm vs< 1 mm - 2293.025 2.31
Localisationa - 2276.934 1.74
Sex - 2270.295 1.54
Level> III vs II - 2263.447 3.82
Tumour thickness>4 mm vs>2-4 mm - 2256.244 1.94
aExtremities and face vs other localisations P<0.0001.
dying of melanoma associated with a given factor under
otherwise identical conditions. The only secondary
significance of Clark's level that is shown by the results of
multivariate analysis, permits a recalculation of the survival
rates that leaves this variable out of account. In the case of
both the thickness grading of the 1978 TNM classification,
and that of the 1987 version, this leads to a greater
differentiation of the original four curves. Expressed in statis-
tical figures there is an increase in the overall chi square
value and in the chi square values of the individual groups
(Table IV).
Cutoffpoints in Breslow's thickness
Any reconsideration of the definition of tumour thickness
cutoff points must be based on a knowledge of the relation-
ship between tumour thickness and survival rates. For this
purpose, therefore, the spectrum of tumour thickness was
divided up into sixteen groups, and the 5-year survival rates
calculated for each. Figure 2 shows the indirectly propor-
tional relationship between tumour thickness and 5-year sur-
vival rate, with a largely constant curve - abrupt changes do
not occur. This circumstance permits a reappraisal of the
cutoff points in terms of a particularly favourable and
homogeneous classification into prognostic groups. Cutoffs at
1, 2 and 4 mm would appear to best serve our purpose
(Table III), in particular in comparison with the grading in
accordance with tumour thickness parameters as employed
by the TNM classifications of 1978 and 1987 (Figure 3).
The prognosis ofadvanced stages
Stage II of the 1978 TNM classification includes patients
with satellite and in-transit metastases, as also patients with
regional lymph node metastases. When the survival rates are
calculated separately for the two groups, however, a
significant difference is found. Approximately 27% of the
patients with satellite or in-transit metastases achieve survival
rates of ten years or more, but when lymph node metastases
are present, the 10-year survival rate decreases to approx-
imately 19%.
A similar situation exists for Stage III of the 1987 TNM
version, in which both patients with very thick primary
tumours and those with regional lymph node metastases are
classified together. While the former have a 10-year survival
rate of 45.8%, lymph node involvement is associated with a
survival rate of only 19%, that is, of less than one-half. If
during the course of the tumour disease, metastatic spread to
the juxtaregional lymph nodes occurs, the 1978 TNM
classification requires an assignment to Stage III. Only 19
patients in our population were assigned to this stage, either
Table IV Comparison ofchi square figures with and without consideration of
Clark's-level
x2figures
Tumour thickness with Clark's-level without Clark's-level
<0.75 mm
vs 7.7 9.2
>0.75- 1.5 mm
>0.75- 1.5 mm
vs 33.5 33.8
>1.5-3mm
>0.75-1.5 mm
vs 49.2 50.6
>1.5-4 mm
Overall x2-figure:
Cutoffs at 0.75/1.5/3 mm: 255.0 269.3
Cutoffs at 0.75/1.5/4 mm: 232.2 268.5PROGNOSIS OF PRIMARY AND METASTASISING MELANOMA 859
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Figure 2 Relationship between tumour thickness and 5-year survival rate in malignant melanoma.
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Figure 3 Ten-year survival rates in accordance with tumour thickness cut off points at 1, 2 and 4 mm.
primarily or during the course of the disease. For this group
the 10-year survival rate was less than 8%.
Discussion
The multivariate analysis revealed tumour thickness to be the
parameter with the greatest prognostic significance. This was
in agreement with the results of the majority of previously
performed studies that differed considerably both with
respect to the choice of parameters investigated, and in the
size of the patient populations involved (Balch et al., 1982;
1985; Day et al., 1982; Garbe et al., 1990).
The discussion as to the choice of suitable interval cutoffs
for thickness gradings with different risks turned on the
question as to the presence of so-called 'natural breakpoints'
(Day et al., 1981). Neither Breslow's original grading with
the cutoffs 0.75, 1.5 and 3 mm (Breslow, 1970), nor cutoffs at
0.75, 1.5 and 4 mm (UICC, 1987) are based on a statistically
founded confirmation of these 'breakpoints'. An indirectly
proportional relationship between tumour thickness and sur-
vival, observed in our study on the basis of a univariate
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analysis, is also confirmed by multivariate analysis (Balch et
al., 1985; Day et al., 1982; Karakousis et al., 1989).
The significant sharp jumps in the survivial probability
with increasing thickness of tumour reported by various
authors on the basis of mutlivariate calculations (Day et al.,
1981; Meyskens et al., 1989), may be artefacts associated
with the statistical methods employed. Multivariate Cox
analysis requires a stage coding into numerous-and thus
numerically very small-subgroups. The significance of the
observation of 'natural breakpoints', however, is greatly
dependent upon the size of the patient groups examined. This
point would also appear to be the possible explanation for
the different position of the 'natural breakpoints' reported by
various authors.
In addition to the advantage of its simplicity in use, the
classification we suggest (cutoffs at 1, 2 and 4 mm), enables a
uniform distribution of patients within Stage I, as measured
by the overall chi square value in the Lee-Desu statistics.
The problematic role of Clark's level as a prognostic
criterion is reflected by the numerous studies on this point.
Although Clark's proposal for tumour staging on the basis of
depth of invasion, would appear to be biologically meaning-
ful, statistical analyses have shown that tumour thickness is
superior in terms of its prognostic information (Balch et al.,
1978; Berdeaux et al., 1989; Day et al., 1982; Drzewiecki et
al., 1990; Johnson et al., 1985; Meyskens et al., 1989; Rogers
et al., 1986).
The use of a combination of tumour thickness and
invasion level - as proposed in the TNM classifications
(UICC et al., 1978; 1987) - has, to date, not been supported
by statistical studies, and on the basis of our results does not
appear to offer any advantage; indeed, when account is not
longer taken of Clark's level, the selectivity of the
classification scheme is even found to be sharpened. The
multivariate analysis, too, shows that the level of invasion
ranges after tumour thickness, localisation of the tumour and
sex of the patient in terms of prognostic significance, and
that the significance it does have is limited to the different-
iation between the levels II and III, in particular in thin
tumours. Since, however, the prognosis ofthese thin tumours
is extremely favourable anyway, taking additional account of
the level of invasion is of only slight clinical relevance.
In comparison with the large number of papers on the
prognosis of primary melanoma (Cascinelli et al., 1986;
Chanda, 1986; Salman & Rogers, 1990; Shaw et al., 1985),
only little attention has been paid to an assessment of the
stages showing metastasis. Nevertheless, the results of our
analyses in this respect make two points clear:
Table V Proposal for a prognosis-oriented TNM revision
Stage Ia pT1 pNO pMO
lb pT2 pNO pMO
Stage Ila pT3 pNO pMO
IIb : pT4 pNO pMO
Stage Illa every pTa,pTb pNO pMO
IlIb every pT pNI pMO
every pTa,pTb pN1 pMO
Stage IV every pT every pN pMI
pTl: tumourthickness,( 1 mm pNl: regional lymph node metastasis
pT2: tumour thickness>1-2 mm pM1: distant metastasis
pT3: tumour thickness>2-4 mm pTa: satellite metastasis
pT4: tumour thickness>4 mm pTb: in-transit-metastasis
Months
-U- Stage la Stage lb - - Stage Ila x Stage lib
-X- Stage Ilila Stage Illb I- Stage IV
Figure 4 Ten-year survival rates in accordance with the criteria of the proposed prognosis oriented TNM version.
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In the first place, the separation of cases of thick primary
tumours from cases of locoregional metastasis, proves to be
meaningful for a prognosis-oriented classification. On the
other hand, account must be taken of the considerably prog-
nostic spectrum of metastasising melanomas by differ-
entiating between locoregional and distant metastatic disease.
Furthermore, in the case of locoregional metastasis, a
differentiation must be made between satellite and in-transit
metastasis on the one and regional lymph nodes metastasis
on the other.
Taking these results as our basis, we have worked out a
proposal for an improved TNM classification. Changes vis-a-
vis the present TNM classifications are oriented to the points
listed below:
- The anatomic spread of the tumour is retained as the
basic principle for the TNM classification.
- Account is taken of the wide prognostic variance shown
by primary melanomas by separating them into four
groups (Ia,b,c,d), while optimising the parameter tumour
thickness.
- Significant differences in terms of prognosis are to be
found between the stages and within their subgroups. The
variations in the subcategories, however, must not call
into question their logical assignment to a common stage.
- The TNM conditions should be equally applicable to all
primary localisations. For this reason and also on account
of the small prognostic differences, juxtaregional lymph
Table VI Ten-year survival rates-prognosis-oriented TNM
version
Ten-year survival rates:
prognosis-oriented TNM version
Stage Ia 93.1%
Stage lb 80.0%
Stage IIa 58.5%
Stage Ilb 42.6%
Stage IIIa 27.7%
Stage IIIb 19.4%
Stage IV 2.6%
node metastases are treated like distant metastases, and
are assigned to a common stage.
The criteria of this new classification are summarised in
Table V and the associated survival rates are shown in
Figure 4 and Table VI.
The model proposed represents a synthesis of the TNM
classifications that are commonly exmployed at the present
time, and the results of statistical analysis. It is tailored to
the biological process of tumour progression, facilitates
clinical management, separates groups with clearly differing
requirements in terms of treatment and after-care, and makes
possible a differentiated prognostic assessment of different
tumour constellations.
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